SCHEMBL6674347

SCHEMBL6674347

CCN(Cc1cccc([N+](=O)[O-])c1)C(=O)OC(C)(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
ALDH1A1 P00352 4/20 0.48
MAPT P10636 4/20 0.48
LMNA P02545 3/20 0.48
PYCR1 P32322 1/20 0.46
ACHE P22303 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
SLC2A1 P11166 1/20 0.44
ALOX5 P09917 1/20 0.44
MAOB P27338 2/20 0.44
MAOA P21397 1/20 0.44
TSHR P16473 1/20 0.43
FAAH O00519 1/20 0.43
MGLL Q99685 1/20 0.43
HTT P42858 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15498167 0.91 CYP1A2 (0.49) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL9900623 0.89 ALDH1A1 (0.51) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL3127049 0.88 ALDH1A1 (0.56) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL3126878 0.87 CYP1A2 (0.45) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL18994885 0.87 ALDH1A1 (0.46) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL30877118 0.86 ALDH1A1 (0.51) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL16468408 0.86 ALDH1A1 (0.51) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL6679985 0.86 CYP2D6 (0.51) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL16467912 0.85 ALDH1A1 (0.50) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL30877102 0.85 ALDH1A1 (0.50) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0798292-B1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY CHUGAI SEIYAKUKABUSHIKI KAISHA (JP) 2004-11-03 EP disclosed
US-6534546-B1 Guanidine- or isothioureido-N-derived anilines; brain, nervous system, and neurodegenerative disorders CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-18 US disclosed
EP-0798292-A1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY Chugai Seiyaku Kabushiki Kaisha (JP) 1997-10-01 EP disclosed